Short-term trading advice for US crude oil: trade within the range, sell on rallies, buy on dips.

智通财经2026/08/17 02:21

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

(1) Analysis rationale: The navigation through the Strait of Hormuz has visibly slowed down, and supply risks continue to support oil prices, but volatility still has not decreased. In the short term, sentiment will likely continue to be affected by geopolitical tensions. On the technical side, the daily chart maintains a relatively strong range structure; there is still rebound potential above $80, with strong resistance near $85. Until there is a significant change in fundamentals, maintain a range-based approach and wait for a clear direction. (2) Key focus: geopolitical tensions, inventory data, US Dollar Index (3) Resistance: 83.00, 83.60, 84.00 (4) Support: 82.00, 81.50, 81.00

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

AstraZeneca (AZN.US) has announced the termination of its clinical trial for the experimental drug volrustomig, after recent data indicated that the drug does not appear to provide superior results to existing therapies in lung cancer treatment. The latest update from AstraZeneca’s eVOLVE-Lung02 phase III clinical trial showed that volrustomig was not more effective than the blockbuster drug Keytruda in treating patients with low PD-L1 expression metastatic non-small cell lung cancer. Both drug

智通财经•2026/08/17 06:56

Rate hike expectations ease, US dollar approaches over two-month low, gold prices edge higher on Monday

智通财经•2026/08/17 06:56